Sunday 28 May 2017
Wednesday 24 May 2017
WHO AND AFRICA
WORLD HEALTH ORGANIZATION AND AFRICA
The World Health Organization has come of age. Established as an organ of the United Nations Organization, she has achieved a lot in addressing the world health challenges as they crop up. WHO living up to her name, she has tried to balance the scale of disease control and its numerous organs or subsectors. It is pertinent to note that since WHO came onboard, the Africans who represent a focus significant global disease burden has consistently suffered under representaion in every aspect of the World Health Organization. The African continent lags behind lacking fair representaion and this means most of the time, while discussions on health challenges presented by the prevalence of many disease in Africa, the proverbial becomes our lot as the main frame fails to come on focus. That is why we all on one accord, welcome with joy, the appointment and emergence of Dr. Tedros Adhanom Ghebreyesus as the ipso facto Director General of the World Health Organization.
His appointment comes at a time when we were all seemingly relaxing on our oars as the diseases that presented a global challenge over the past 6 years aparently declined but suddenly relapsed with threatening alacrity. Ebola outbreak with its devastating consequences is being recorded in Central Africa and given the level of increasing transhuman development, fear now pervades the air that a continental pandemic might recur if co-ordinated actions are not put in place to check the current incidence. Dr. Ghebyreyesus therefore, has a lot on his hands. He has to rise to the occasion and demonstrate that the trust reposed in him is not in vain. The current Director General has other areas he has to beam his searchlight. Africa is under represented still in the WHO and particularly, in the PMNCH, a current resentative for Africa at the World Health Assembly is from Sri Lanka. This remains an abberration thuogh this discrepancy was incident on tribalism and bigotry among Africans. The Director General must therefore not ignore the fact and so should throw his lot to re-educate our people to learn to think out of the box. Dr. Ghebyreyesus has had a long career in the health care industry both at home and abroad and so he is no stranger to the enormous challenges waiting at his desk. Welcome, our new Director General.
Dr. Ikechukwu E. Onyekwelonwu MBBCH,
President, RCHC
The World Health Organization has come of age. Established as an organ of the United Nations Organization, she has achieved a lot in addressing the world health challenges as they crop up. WHO living up to her name, she has tried to balance the scale of disease control and its numerous organs or subsectors. It is pertinent to note that since WHO came onboard, the Africans who represent a focus significant global disease burden has consistently suffered under representaion in every aspect of the World Health Organization. The African continent lags behind lacking fair representaion and this means most of the time, while discussions on health challenges presented by the prevalence of many disease in Africa, the proverbial becomes our lot as the main frame fails to come on focus. That is why we all on one accord, welcome with joy, the appointment and emergence of Dr. Tedros Adhanom Ghebreyesus as the ipso facto Director General of the World Health Organization.
His appointment comes at a time when we were all seemingly relaxing on our oars as the diseases that presented a global challenge over the past 6 years aparently declined but suddenly relapsed with threatening alacrity. Ebola outbreak with its devastating consequences is being recorded in Central Africa and given the level of increasing transhuman development, fear now pervades the air that a continental pandemic might recur if co-ordinated actions are not put in place to check the current incidence. Dr. Ghebyreyesus therefore, has a lot on his hands. He has to rise to the occasion and demonstrate that the trust reposed in him is not in vain. The current Director General has other areas he has to beam his searchlight. Africa is under represented still in the WHO and particularly, in the PMNCH, a current resentative for Africa at the World Health Assembly is from Sri Lanka. This remains an abberration thuogh this discrepancy was incident on tribalism and bigotry among Africans. The Director General must therefore not ignore the fact and so should throw his lot to re-educate our people to learn to think out of the box. Dr. Ghebyreyesus has had a long career in the health care industry both at home and abroad and so he is no stranger to the enormous challenges waiting at his desk. Welcome, our new Director General.
Dr. Ikechukwu E. Onyekwelonwu MBBCH,
President, RCHC
Monday 22 May 2017
UPDATING MEMBERS ON NEW TRENDS ON HIV/AIDS
KEY FEATURES and changes in 2016 HIV national guideline
1. Test and start - All people who test positive to HIV should commence ART immediately, irrespective of CD4 count after baseline investigations
2. Re testing. All who test positive to HIV must be retested by another person to avoid false positives
3. High risk babies born to HIV positive mothers with high viral load >1000copies/ml or unbooked HIV positive woman presenting in labour etc, should be placed on syrup Nevirapine + syr zidovudine for 12weeks
4 option B+. All HIV positive mothers or that tested positive at ANC should be placed on ART immediately and continued for life. HIV positive pregnant women on ART are to do viral load 32-36wks GA. Baby should be commenced on syr Nevirapine within 72hrs of delivery for 6weeks, after which DBS is done and child started on cotrimoxazole till HIV is ruled out. NB if high risk infant give syr Nevirapine +zidovudine for 12weeks.
2. Re testing. All who test positive to HIV must be retested by another person to avoid false positives
3. High risk babies born to HIV positive mothers with high viral load >1000copies/ml or unbooked HIV positive woman presenting in labour etc, should be placed on syrup Nevirapine + syr zidovudine for 12weeks
4 option B+. All HIV positive mothers or that tested positive at ANC should be placed on ART immediately and continued for life. HIV positive pregnant women on ART are to do viral load 32-36wks GA. Baby should be commenced on syr Nevirapine within 72hrs of delivery for 6weeks, after which DBS is done and child started on cotrimoxazole till HIV is ruled out. NB if high risk infant give syr Nevirapine +zidovudine for 12weeks.
Implications of 2016 HIV guideline
1. Health care workers are to commence their pre-ART pool of clients (those with HIV but CD4>500)on ART after retesting.
2.More health workers are needed as PMTCT sites and ART sites will be flooded more clients on ART.
3. Our youths need to hear word in OVD's voice
1. Health care workers are to commence their pre-ART pool of clients (those with HIV but CD4>500)on ART after retesting.
2.More health workers are needed as PMTCT sites and ART sites will be flooded more clients on ART.
3. Our youths need to hear word in OVD's voice
In addition 3new drugs has been added to the current ART drugs-Dolutegravir( integrase inhibitor), Raltegravir (integrase inhibitor), Darunavir (protease inhibitor
Thanks
God bless our HIV clients
God bless our HIV clients
UPDATE ON HIV/AIDS
KEY FEATURES and changes in 2016 HIV national guideline
1. Test and start - All people who test positive to HIV should commence ART immediately, irrespective of CD4 count after baseline investigations
2. Re testing. All who test positive to HIV must be retested by another person to avoid false positives
3. High risk babies born to HIV positive mothers with high viral load >1000copies/ml or unbooked HIV positive woman presenting in labour etc, should be placed on syrup Nevirapine + syr zidovudine for 12weeks
4 option B+. All HIV positive mothers or that tested positive at ANC should be placed on ART immediately and continued for life. HIV positive pregnant women on ART are to do viral load 32-36wks GA. Baby should be commenced on syr Nevirapine within 72hrs of delivery for 6weeks, after which DBS is done and child started on cotrimoxazole till HIV is ruled out. NB if high risk infant give syr Nevirapine +zidovudine for 12weeks.
2. Re testing. All who test positive to HIV must be retested by another person to avoid false positives
3. High risk babies born to HIV positive mothers with high viral load >1000copies/ml or unbooked HIV positive woman presenting in labour etc, should be placed on syrup Nevirapine + syr zidovudine for 12weeks
4 option B+. All HIV positive mothers or that tested positive at ANC should be placed on ART immediately and continued for life. HIV positive pregnant women on ART are to do viral load 32-36wks GA. Baby should be commenced on syr Nevirapine within 72hrs of delivery for 6weeks, after which DBS is done and child started on cotrimoxazole till HIV is ruled out. NB if high risk infant give syr Nevirapine +zidovudine for 12weeks.
Implications of 2016 HIV guideline
1. Health care workers are to commence their pre-ART pool of clients (those with HIV but CD4>500)on ART after retesting.
2.More health workers are needed as PMTCT sites and ART sites will be flooded more clients on ART.
3. Our youths need to hear word in OVD's voice
In addition 3new drugs has been added to the current ART drugs-Dolutegravir( integrase inhibitor), Raltegravir (integrase inhibitor), Darunavir (protease inhibitor
We wish all HIV/AIDS patients speedy recovery.
Thank you
Thank you
Friday 19 May 2017
LISTEN TO YOUR NAILS
Our nails could be signal flags to show when certain organs are having problems. These clips could be resourceful as hints.
Monday 15 May 2017
Partnership upcoming events calendar
| ||||||||||||||
|
Subscribe to:
Posts (Atom)